ACAD
Price
$25.26
Change
-$0.24 (-0.94%)
Updated
Sep 5 closing price
Capitalization
4.26B
66 days until earnings call
AVCTF
Price
$0.83
Change
+$0.12 (+16.90%)
Updated
Sep 2 closing price
Capitalization
295.91M
Interact to see
Advertisement

ACAD vs AVCTF

Header iconACAD vs AVCTF Comparison
Open Charts ACAD vs AVCTFBanner chart's image
ACADIA Pharmaceuticals
Price$25.26
Change-$0.24 (-0.94%)
Volume$1.11M
Capitalization4.26B
Avacta Group
Price$0.83
Change+$0.12 (+16.90%)
Volume$4K
Capitalization295.91M
ACAD vs AVCTF Comparison Chart in %
Loading...
ACAD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
AVCTF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ACAD vs. AVCTF commentary
Sep 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ACAD is a Hold and AVCTF is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 06, 2025
Stock price -- (ACAD: $25.26 vs. AVCTF: $0.83)
Brand notoriety: ACAD and AVCTF are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ACAD: 61% vs. AVCTF: 148%
Market capitalization -- ACAD: $4.26B vs. AVCTF: $295.91M
ACAD [@Biotechnology] is valued at $4.26B. AVCTF’s [@Biotechnology] market capitalization is $295.91M. The market cap for tickers in the [@Biotechnology] industry ranges from $101.56B to $0. The average market capitalization across the [@Biotechnology] industry is $1.91B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ACAD’s FA Score shows that 1 FA rating(s) are green whileAVCTF’s FA Score has 0 green FA rating(s).

  • ACAD’s FA Score: 1 green, 4 red.
  • AVCTF’s FA Score: 0 green, 5 red.
According to our system of comparison, ACAD is a better buy in the long-term than AVCTF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ACAD’s TA Score shows that 2 TA indicator(s) are bullish while AVCTF’s TA Score has 4 bullish TA indicator(s).

  • ACAD’s TA Score: 2 bullish, 5 bearish.
  • AVCTF’s TA Score: 4 bullish, 3 bearish.
According to our system of comparison, AVCTF is a better buy in the short-term than ACAD.

Price Growth

ACAD (@Biotechnology) experienced а -2.81% price change this week, while AVCTF (@Biotechnology) price change was +16.50% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.52%. For the same industry, the average monthly price growth was +14.52%, and the average quarterly price growth was +33.01%.

Reported Earning Dates

ACAD is expected to report earnings on Nov 11, 2025.

Industries' Descriptions

@Biotechnology (+2.52% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ACAD($4.26B) has a higher market cap than AVCTF($296M). AVCTF YTD gains are higher at: 46.690 vs. ACAD (37.657).
ACADAVCTFACAD / AVCTF
Capitalization4.26B296M1,440%
EBITDA104MN/A-
Gain YTD37.65746.69081%
P/E Ratio18.99N/A-
Revenue1.02BN/A-
Total Cash762MN/A-
Total Debt56.3MN/A-
FUNDAMENTALS RATINGS
ACAD: Fundamental Ratings
ACAD
OUTLOOK RATING
1..100
76
VALUATION
overvalued / fair valued / undervalued
1..100
61
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
29
PRICE GROWTH RATING
1..100
41
P/E GROWTH RATING
1..100
99
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ACADAVCTF
RSI
ODDS (%)
Bearish Trend 1 day ago
64%
Bearish Trend 1 day ago
54%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
65%
Bearish Trend 1 day ago
55%
Momentum
ODDS (%)
N/A
Bullish Trend 1 day ago
29%
MACD
ODDS (%)
Bearish Trend 1 day ago
77%
Bullish Trend 1 day ago
36%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
69%
Bullish Trend 1 day ago
32%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
79%
Bullish Trend 1 day ago
34%
Advances
ODDS (%)
Bullish Trend 11 days ago
74%
N/A
Declines
ODDS (%)
Bearish Trend 1 day ago
69%
N/A
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
80%
Bearish Trend 1 day ago
82%
Aroon
ODDS (%)
Bullish Trend 1 day ago
78%
Bullish Trend 1 day ago
30%
View a ticker or compare two or three
Interact to see
Advertisement
ACAD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
AVCTF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MKFOX9.16N/A
N/A
BlackRock Large Cap Focus Growth K
VSRAX24.88N/A
N/A
Invesco Small Cap Value R
SEPKX60.52-0.02
-0.03%
Allspring Mid Cap Growth Fund - Cl Admin
BLYPX35.07-0.03
-0.09%
American Beacon Man Lg Cp Growth Inv
WPLCX17.04-0.29
-1.67%
WP Large Cap Income Plus Institutional

ACAD and

Correlation & Price change

A.I.dvisor indicates that over the last year, ACAD has been loosely correlated with AURA. These tickers have moved in lockstep 40% of the time. This A.I.-generated data suggests there is some statistical probability that if ACAD jumps, then AURA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ACAD
1D Price
Change %
ACAD100%
-0.94%
AURA - ACAD
40%
Loosely correlated
+0.93%
STTK - ACAD
40%
Loosely correlated
+2.65%
CRSP - ACAD
39%
Loosely correlated
+4.02%
RXRX - ACAD
38%
Loosely correlated
+1.99%
SYRE - ACAD
38%
Loosely correlated
+0.06%
More

AVCTF and

Correlation & Price change

A.I.dvisor tells us that AVCTF and NAUT have been poorly correlated (+29% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that AVCTF and NAUT's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AVCTF
1D Price
Change %
AVCTF100%
N/A
NAUT - AVCTF
29%
Poorly correlated
+1.41%
ACAD - AVCTF
24%
Poorly correlated
-0.94%
EPRX - AVCTF
24%
Poorly correlated
+0.56%
KZIA - AVCTF
23%
Poorly correlated
-4.08%
FBRX - AVCTF
23%
Poorly correlated
+2.74%
More